Forbion European Acquisition (Nasdaq:FRBN) - Stock Price, News & Analysis

FRBN Stock Overview

Forbion European Acquisition Corp. does not have significant operations. More details

FRBN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Makes less than USD$1m in revenue ($0)

Negative shareholders equity

Highly volatile share price over the past 3 months

Has less than 1 year of cash runway

+ 1 more risk

Forbion European Acquisition Corp. Competitors

Saratoga Investment

NYSE:SAR

US$352.3m

Helios Fairfax Partners

OTCPK:FFXX.F

US$293.2m

ASA Gold and Precious Metals

NYSE:ASA

US$387.8m

Nabors Energy Transition II

NasdaqGM:NETD

US$409.5m

Price History & Performance

Summary of all time highs, changes and price drops for Forbion European Acquisition
Historical stock prices
Current Share Price	US$21.70
52 Week High	US$47.17
52 Week Low	US$9.25
Beta	0
11 Month Change	99.40%
3 Month Change	101.25%
1 Year Change	113.74%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	120.03%

Recent updates

Shareholder Returns

	FRBN	US Capital Markets	US Market
7D	21.5%	0.06%	0.5%
1Y	113.7%	52.3%	30.7%

Return vs Industry: FRBN exceeded the US Capital Markets industry which returned 8% over the past year.

Return vs Market: FRBN exceeded the US Market which returned 14.1% over the past year.

Price Volatility

Is FRBN's price volatile compared to industry and market?
FRBN volatility
FRBN Average Weekly Movement	34.8%
Capital Markets Industry Average Movement	3.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: FRBN's share price has been volatile over the past 3 months.

Volatility Over Time: FRBN's weekly volatility has increased from 20% to 35% over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Jasper Bos	forbion.com/en/feac/

Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe.

Forbion European Acquisition Corp. Fundamentals Summary

How do Forbion European Acquisition's earnings and revenue compare to its market cap?
FRBN fundamental statistics
Market cap	US$343.05m
Earnings (TTM)	-US$3.23m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-106.3x

P/E Ratio

Is FRBN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FRBN income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$3.23m
Earnings	-US$3.23m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.20
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	-27.4%

How did FRBN perform over the long term?

See historical performance and comparison

Forbion European Acquisition NasdaqGM:FRBN Stock Report